 DURHAM, N.C.--BUSINESS WIRE--Istari Oncology, Inc., a clinical-stage biotechnology company today announced that Marc Banjak has joined the company as general counsel and secretary. Mr. Banjak comes to Istari from Dova Pharmaceuticals NASDAQ: DOVA, where he led the legal and compliance teams. While at Dova, he helped guide the companys lead product through two regulatory approvals by the US Food and Drug Administration for the treatment of thrombocytopenia. In addition to FDA milestones, he 